Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis

IntroductionVenous thromboembolism (VTE) occurrence in patients with lung cancer is associated with significant morbidity and mortality. The Khorana Score (KRS) is a validated risk stratification tool developed to estimate risk of VTE in patients with cancer that incorporates clinical and laboratory...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sean C. Dougherty, Rishika Singh, Caleb McKinney, Aditya Singh, Jack Masur, Alia C. Lynch, Ryan D. Gentzler, Wendy Novicoff, Nathan Roberts, Richard D. Hall
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2026-01-01
Цуврал:	Frontiers in Oncology
Нөхцлүүд:	khorana risk score non-small cell lung cancer oncogenic driver mutation small cell lung cancer venous thromboembolism
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1651192/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!